1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII

被引:32
作者
Calderone, Vincenzo [1 ]
Fiamingo, Francesca Lidia [2 ]
Amato, Gabriella [2 ]
Giorgi, Irene [2 ]
Livi, Oreste [2 ]
Martelli, Alma [1 ]
Martinotti, Enrica [1 ]
机构
[1] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, I-56126 Pisa, Italy
[2] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy
关键词
BK-potassium channel; Triazole-carboxamide; Triazole-carboxanilide; BK-activator;
D O I
10.1016/j.ejmech.2008.02.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The chemical structures of many synthetic activators of large-conductance calcium-activated potassium channels (BK channels) satisfy a simple pharmacophore model, consisting of two appropriately substituted phenyl rings connected by a linker of a heterogeneous nature. In this paper, a series of new compounds with modifications of the linker portion of the above pharmacophore are described. In particular, in these new derivatives, the linker portion is represented by a 1,2,3-triazole-carboxamide group, which can be viewed as a combination of two different kinds of linker, independently used in previous series of BK-openers: the amide function and the 1,2,3-triazole ring. The overall finding of this study indicated that the triazole-carboxamide derivatives were generally poorly effective and that this structural modification of the linker is deleterious for activity on BK channels. Therefore, it can be hypothesized that the increase of the steric hindrance of the linker and/or the increase of the distance between the two aromatic portions are negative for the interaction with the biological target. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:2618 / 2626
页数:9
相关论文
共 20 条
[1]  
Amegadzie A. K., 2005, Patent, Patent No. [WO2005000821 A1, 2005000821]
[2]   Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II [J].
Baragatti, B ;
Biagi, G ;
Calderone, V ;
Giorgi, I ;
Livi, O ;
Martinotti, E ;
Scartoni, V .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (10) :949-955
[3]   Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V [J].
Biagi, G ;
Giorgi, I ;
Livi, O ;
Nardi, A ;
Calderone, V ;
Martelli, A ;
Martinotti, E ;
Salerni, OL .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (06) :491-498
[4]   Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III [J].
Biagi, G ;
Calderone, V ;
Giorgi, I ;
Livi, O ;
Scartoni, V ;
Baragatti, B ;
Martinotti, E .
FARMACO, 2001, 56 (11) :841-849
[5]   New 5-substituted-1-(2-hydroxybenzoyl)-benzotriazoles, potassium channel activators. IV [J].
Biagi, G ;
Giorgi, I ;
Livi, O ;
Scartoni, V ;
Barili, PL ;
Calderone, V ;
Martinotti, E .
FARMACO, 2001, 56 (11) :827-834
[6]   5-(4′-substituted-2′-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators.: I [J].
Biagi, G ;
Calderone, V ;
Griorgi, I ;
Livi, O ;
Scartoni, V ;
Baragatti, B ;
Martinotti, E .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (7-8) :715-720
[7]  
Biagi G, 1996, FARMACO, V51, P601
[8]  
Biagi Giuliana, 2004, Farmaco (Lausanne), V59, P397, DOI 10.1016/j.farmac.2004.01.012
[9]   REGULATION OF ARTERIAL TONE BY ACTIVATION OF CALCIUM-DEPENDENT POTASSIUM CHANNELS [J].
BRAYDEN, JE ;
NELSON, MT .
SCIENCE, 1992, 256 (5056) :532-535
[10]   Benzoyl and/or benzyl substituted 1,2,3-triazoles as potassium channel activators. VIII [J].
Calderone, V ;
Giorgi, I ;
Livi, O ;
Martinotti, E ;
Mantuano, E ;
Martelli, A ;
Nardi, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (06) :521-528